---
id: antimicrobials_tmp-smx-pcp-prophylaxis_021
category: antimicrobials
tags: [antimicrobials, tmp-smx, PCP, prophylaxis, HIV, CD4]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## TMP-SMX for PCP Prophylaxis and Treatment

**Q:** When should PCP prophylaxis be initiated in HIV patients, and what are the dosing regimens for prophylaxis and treatment with TMP-SMX?

**A:**

**Prophylaxis Indications:**
- **CD4 <200 cells/µL** (strongest indication)
- CD4 <100 cells/µL regardless of viral load
- CD4 100-200 with detectable HIV RNA
- CD4% <14%
- History of oropharyngeal candidiasis (thrush)

**Prophylaxis Dosing:**
- **Preferred:** TMP-SMX DS (800/160 mg) 1 tablet daily
- **Alternative:** TMP-SMX SS (400/80 mg) 1 tablet daily (better tolerated)
- **Alternative:** TMP-SMX DS 1 tablet three times weekly (Monday-Wednesday-Friday)

**Can discontinue prophylaxis when:**
- CD4 ≥200 cells/µL for ≥3 months on ART
- Some discontinue at CD4 100-200 if undetectable viral load x 3-6 months

**Treatment Dosing:**
- **15-20 mg/kg/day** (based on TMP component) divided TID-QID x 21 days
- Example: 70 kg patient = 2 DS tablets TID

**Adjunctive steroids indicated if:**
- PaO₂ <70 mmHg OR
- A-a gradient >35 mmHg
- Give prednisone 40 mg BID x 5 days → 40 mg daily x 5 days → 20 mg daily x 11 days

**Mnemonic: "CD4 less than TWO hundred, give prophylaxis x TWO (DS tablets or times weekly)"**

| **Indication** | **CD4 Threshold** | **Additional Criteria** |
|----------------|-------------------|-------------------------|
| **Primary prophylaxis** | <200 cells/µL | Strong indication |
| Alternate trigger | <100 cells/µL | Any viral load |
| Alternate trigger | 100-200 cells/µL | Detectable HIV RNA |
| **Discontinue** | ≥200 cells/µL | ≥3 months on ART |

**Media:** None

**Sources:** [NIH HIV/AIDS OI Guidelines 2024], [IDSA/ATS PCP Guidelines], [Cochrane Review 2024]
